Within the whole cohort, 11% of cases received NACT (n = 228) and SAMHD1 expression was evaluated in all infiltrating ductal carcinoma cases with follow-up (n = 182) that do not achieve pCR (n = 151, Fig. 1A). Here, SAMHD1 is linked to invasive ductal breast carcinoma.